(3S,4S)-1-(tert-Butoxycarbonyl)-3-hydroxypiperidine-4-carboxylic acid

Catalog No.: 
ACZSKL083
CAS No.: 
2361920-79-6
Molecular Formula: 
C11H19NO5
Molecular Weight: 
245.27
(3S,4S)-1-(tert-Butoxycarbonyl)-3-hydroxypiperidine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3S,4S)-1-(tert-Butoxycarbonyl)-3-hydroxypiperidine-4-carboxylic acid
IUPAC Name(3S,4S)-1-(tert-butoxycarbonyl)-3-hydroxypiperidine-4-carboxylic acid
Molecular FormulaC11H19NO5
Molecular Weight245.27
SMILESO=C(N1C[C@@H](O)[C@@H](C(O)=O)CC1)OC(C)(C)C
InChI KeyRIZCQEWQJRFDHL-JGVFFNPUSA-N
Synonym(3S,4S)-1-(tert-Butoxycarbonyl)-3-hydroxypiperidine-4-carboxylic acid;1,4-Piperidinedicarboxylic acid, 3-hydroxy-, 1-(1,1-dimethylethyl) ester, (3S,4S)-
CAS No.2361920-79-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233

Synthetic Route by SureRoute

1. ACZSKL083 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSGMI148 route compound structure diagram
    ACSGMI1482271349-56-3In Stock
  2. Then
  3. ACZSKL083 route product structure diagram
    ACZSKL0832361920-79-6
Inquiry

2. ACZSKL083 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZSKL083 route product structure diagram
    ACZSKL0832361920-79-6
Inquiry

3. ACZSKL083 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZSKL083 route product structure diagram
    ACZSKL0832361920-79-6
Inquiry

Comments (0)